Skip to main content

Learning from patient-derived autoantibodies to understand human tumor biology and identify new targets.

18 Jun 2024
Salon D
Tumor Microenvironment (TME)
  • Why cancer patients develop anti-cancer autoantibodies?
  • How to isolate those antibodies?
  • How to leverage the spontaneous antibody response for target and therapy discovery?
Industry Expert
Xingfeng Bao, VP Head of Biology - GV20 Therapeutics